Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.VasoGenix and Cleveland Clinic collaborate on heart drug
The clinic will prepare a clinical protocol design for a phase I/II trial to be conducted at the clinic and coordinated by its Cardiovascular Coordinating Center. In addition,
The clinic will prepare a clinical protocol design for a phase I/II trial to be conducted at the clinic and coordinated by its Cardiovascular Coordinating Center. In addition,
The placebo-controlled trial enrolled 110 healthy adult males at one center in the US. The primary purpose of the study was to investigate the safety, tolerability and pharmacokinetics
Adult onset spasmodic torticollis/cervical dystonia is a syndrome that causes abnormal involuntary movements or posture of the head and neck, often followed by pain in the back portions
The UK spends more of its healthcare budget on cardiovascular disease than any other country in the European Union, the figures, published in the journal Heart, show. The
UK researchers from South West Kent Primary Care Trust and the University of Bradford looked at 203 females aged from 13 to 20 who got the medication from
This finding comes from a new study conducted in part by researchers at the US National Institutes of Health’s (NIH’s) National Institute of Diabetes and Digestive and Kidney
The company said in a statement that the deal recognizes “the increasing importance of biotechnology in medical research” and that the company plans to establish itself as a
A recent analysis of trial data is said to have shown that Paxil increases the risk of suicide in young adults with major depressive disorder compared to placebo.
The primary objective of this trial is to determine a dose range for the drug that is well tolerated, achieves pharmacologically active plasma concentrations and is appropriate for
The collaboration will initially focus on developing diagnostic tests for genetic variations linked to heart attack, type 2 diabetes and breast cancer. The alliance will employ Illumina's platform